Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Highlights of ASCP 2007 Annual Meeting
Link ID 4139
Title Highlights of ASCP 2007 Annual Meeting
Url http://www.medscape.com/viewprogram/8973?src=rss
Description Read these highlights of the ASCP 2007 Annual Meeting. Medscape Pathology
Category Articles > Hematology-Oncology
Keywords
Date Mar 20, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. NCCN 2nd Annual Congress: Hematologic Malignancies - Blood Products and Growth Factors in the Treatm
  Review some of the most current NCCN guidelines on blood products and growth factors for use in thrombocytopenia.
Category:   Articles > Hematology-Oncology


2. Overall Cancer Incidence and Death Rates Fall Significantly in the United States
  The latest comprehensive statistics show that the incidence and death rates for all cancers combined are decreasing for both men and women. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. FDA Safety Changes: Campath and Trileptal
  The FDA has approved revisions to the safety labeling for alemtuzumab intravenous injection (Campath) and oxcarbazepine tablets/oral suspension (Trileptal). Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Erythropoietin Can Influence Pathologic Proliferation of Blood Vessels, Possibly Influencing Tumor G
  In addition to stimulating the formation of erythrocytes, erythropoietin can enhance pathologic proliferation of blood vessel, and could affect patients with cancer and other conditions related to abnormal blood vessel growth. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Radical Prostatectomy a Good Option for Some Older Men With Prostate Cancer
  For men aged 70 years and older with prostate cancer but without major co-morbidities and who have a life expectancy of at least 10 years, radical retropubic prostatectomy (RRP) is "a real option," a New York investigator told Reuters Health. Reuters Health Information
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS